Own experience with axitinib in the treatment of metastatic renal cell carcinoma

Simple item page
dc.contributor.authorRichter Igorcs
dc.contributor.authorDvořák Josefcs
dc.contributor.authorŠámal Vladimírcs
dc.contributor.authorHejzlarová Věracs
dc.contributor.authorBartoš Jiřícs
dc.date.accessioned2020-06-08T09:38:51Z
dc.date.available20-32-2019en
dc.date.available2020-06-08T09:38:51Z
dc.date.issued2018-01-01cs
dc.date.updated29-03-2019en
dc.format.extent4cs
dc.identifier.issn1802-4475cs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/155555
dc.language.isoczecs
dc.publisherSolencs
dc.publisher.cityOlomouccs
dc.relation.ispartofOnkologieen
dc.relation.ispartofseries1cs
dc.subjectrenal carcinomacs
dc.subjecttargeted therapycs
dc.subjectaxitinibcs
dc.subjecttreatment toxicitycs
dc.subjectoverall survival and progression-free survivalcs
dc.titleOwn experience with axitinib in the treatment of metastatic renal cell carcinomaen
dc.titleVlastní zkušenosti s axitinibem v léčbě metastatického karcinomu ledvinycs
local.citation.epage83-86cs
local.citation.spage83-86cs
local.identifier.publikace6159
local.relation.issue2cs
Files
Collections